Conditioning Impacts on Regulatory T-Cells (Tregs) in the Microenvironment of AML: Observations from the Phase 1 Cynk-001-AML-001 Trial

taniraleucel (CYNK-001) - Celularity, United Therapeutics Corp

https://ash.confex.com/ash/2023/webprogram/Paper189508.html

Eunice S Wang, MD1; Hongtao Liu, MD, PhD2; Daniel N. Egan, MD3; Adrian Kilcoyne, MD4; Bhavani Stout, MSc4; Natalia Ruggeri Barbaro, PhD5; Cherie Daly6; Siyara Kilcoyne5; Robert Hariri, MD, PhD7; James McCloskey, MD8

Nov 3, 2023